Package 0002-9401-01

Brand: kisunla

Generic: donanemab-azbt
NDC Package

Package Facts

Identity

Package NDC 0002-9401-01
Digits Only 0002940101
Product NDC 0002-9401
Product ID 0002-9401_85d3d68b-57f9-45e6-a1a7-fa19bc843f33
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (0002-9401-01) / 20 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2024-07-02
Brand kisunla
Generic donanemab-azbt
Sample Package No

Linked Drug Pages (1)

Kisunla ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "85d3d68b-57f9-45e6-a1a7-fa19bc843f33", "openfda": {"upc": ["0300029401018"], "unii": ["1ADB65P1KK"], "rxcui": ["2687972", "2687979"], "spl_set_id": ["190352d4-ef62-4679-b4fa-e846e2766afa"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0002-9401-01)  / 20 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "0002-9401-01", "marketing_start_date": "20240702"}], "brand_name": "Kisunla", "product_id": "0002-9401_85d3d68b-57f9-45e6-a1a7-fa19bc843f33", "dosage_form": "INJECTION, SOLUTION", "product_ndc": "0002-9401", "generic_name": "donanemab-azbt", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Kisunla", "active_ingredients": [{"name": "DONANEMAB", "strength": "17.5 mg/mL"}], "application_number": "BLA761248", "marketing_category": "BLA", "marketing_start_date": "20240702", "listing_expiration_date": "20261231"}